Search Result "Hodgkin's"
Recent Advances in Nanobiotechnology for the Treatment ofNon-Hodgkinâs Lymphoma
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 24 Issue: 9 Year: 2024 Page: 895-907
Author(s):
Antiangiogenic Therapies in Non-Hodgkins Lymphoma
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1030-1043
Author(s): J. Ruan
Coexistence of Non-Hodgkin's Lymphoma and Acute Myeloid Leukemiaat Initial Diagnosis: A Case Report
Journal: Current Medical Imaging
Volume: 19 Issue: 10 Year: 2023 Page: 1219-1223
Author(s): Meng Meng Ke,Zhi Zhong Wang,Zhi Jun Chen
Hematological Neoplasia and Angiogenesis: A Review
Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Estela Maria Novak
Doi: 10.2174/978160805259211201010122
Nano Conjugated PLGA-Chlorambucil: Synthesis In Vitro Anti Non- Hodgkin's Lymphoma Cellular Assay
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 7 Year: 2017 Page: 827-836
Author(s): Saeed Akbarian, Jafar Sojoodi, Fatemeh Monnavari, Hossein Heidari, Pegah Khosravian, Hamid A. Javar, Artin Assadi, Rahimeh Rasouli, Mostafa Saffari, Seyed A.S. Shandiz, Hadi Hejazinia, Farnoor D. Omoomi, Mohammad Saffari, Mehdi S. Ardestani
Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall
Journal: Current Respiratory Medicine Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 75-78
Author(s): William H. Porr,Jonathan L. Henderson,Michael J. Morris
Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 9 Year: 2019 Page: 681-687
Author(s): Linqing Zou,Guoqi Song,Siyu Gu,Lingling Kong,Shiqi Sun,Li Yang,William C. Cho
Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patientwith Hodgkin's Lymphoma History from North of Iran
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 8 Year: 2021 Page: 12-15
Author(s): David Darvishnia,Mahdieh Sadeghi,Ali Sharifpour,Zakaria Zakariaei,Elham Sadat Banimostafavi,Mahdi Fakhar,Rabeeh Tabaripour
Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A Hypothesis
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 5 Year: 2020 Page: 616-618
Author(s): Kimia Kazemi,Negin Mozafari,Hajar Ashrafi,Pedram Rafiei,Amir Azadi
Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog